TRACY PARKER: Open Payments
NPI 1932243532 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,182 in 42 payments from 24 companies in 2025. Trend: 2023 $3,570 · 2024 $3,304 · 2025 $3,182
Food & beverage: $3,150Education: $32
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $368 |
| GENZYME CORPORATION | 3 | $355 |
| Teva Pharmaceuticals USA, Inc. | 2 | $241 |
| Novo Nordisk Inc | 5 | $205 |
| Abbott Laboratories | 1 | $163 |
| Madrigal Pharmaceuticals | 1 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $140 |
| Organon LLC | 1 | $138 |
| Janssen Biotech, Inc. | 1 | $137 |
| Novartis Pharmaceuticals Corporation | 7 | $136 |
Products named: DUPIXENT, FREESTYLE LIBRE 3, REZDIFFRA, Wegovy, Kerendia, VTAMA, LEQVIO, STRENSIQ.
Industry payments across LA — which companies pay providers there.
